Medical Journals

Evidence of a Potential Receptor-binding Site on the Nipah Virus G Protein (Niv-g): Identification of Globular Head Residues with a Role in Fusion Promotion and Their Localization on an Niv-g Structural Model.

Authors:
  • Guillaume Vanessa
  • Aslan Hamide
  • Ainouze Michelle
  • Guerbois Mathilde
  • Wild T Fabian
  • Buckland Robin
  • Langedijk Johannes P M

From: Molecular Basis of Paramyxovirus Entry, INSERM U404, Centre d’Etudes de Recherche en Virologie et Immunologie, IFR 128 Biosciences Lyon-Gerland, 21 avenue Tony Garnier, 69365 Lyon cedex 07, France.

Journal of virology

  • Publish Date: Aug 2006
  • ISSN: 0022-538X
  • Volume: 80
  • Issue: 15
  • Pages: 7546-54
  • Medium: Print
  • Language: English
  • Citation (JAMA): Guillaume Vanessa, Aslan Hamide, Ainouze Michelle, et al. Evidence of a Potential Receptor-binding Site on the Nipah Virus G Protein (Niv-g): Identification of Globular Head Residues with a Role in Fusion Promotion and Their Localization on an Niv-g Structural Model.. J. Virol. Aug 2006;80:7546-54

Abstract

As a preliminary to the localization of the receptor-binding site(s) on the Nipah virus (NiV) glycoprotein (NiV-G), we have undertaken the identification of NiV-G residues that play a role in fusion promotion. To achieve this, we have used two strategies. First, as NiV and Hendra virus (HeV) share a common receptor and their cellular tropism is similar, we hypothesized that residues functioning in receptor attachment could be conserved between their respective G proteins. Our initial strategy was to target charged residues (which can be expected to be at the surface of the protein) conserved between the NiV-G and HeV-G globular heads. Second, we generated NiV variants that escaped neutralization by anti-NiV-G monoclonal antibodies (MAbs) that neutralize NiV both in vitro and in vivo, likely by blocking receptor attachment. The sequencing of such “escape mutants” identified NiV-G residues present in the epitopes to which the neutralizing MAbs are directed. Residues identified via these two strategies whose mutation had an effect on fusion promotion were localized on a new structural model for the NiV-G protein. Our results suggest that seven NiV-G residues, including one (E533) that was identified using both strategies, form a contiguous site on the top of the globular head that is implicated in ephrinB2 binding. This site commences near the shallow depression in the center of the top surface of the globular head and extends to the rim of the barrel-like structure on the top loops of beta-sheet 5. The topology of this site is strikingly similar to that proposed to form the SLAM receptor site on another paramyxovirus attachment protein, that of the measles virus hemagglutinin.

Mesh Headings (Keywords): Amino Acid Sequence, Animals, Antibodies, Monoclonal, Binding Sites, CHO Cells, Cercopithecus aethiops, Cricetinae, Cricetulus, Ephrin-B2, Humans, Membrane Fusion, Models, Molecular, Molecular Sequence Data, Mutation, Nipah Virus, Receptors, Cell Surface, Sequence Homology, Amino Acid, Vero Cells, Viral Envelope Proteins


Check for Full Text / PubMed Unique Identifier (PMID): 16840334


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.